# FDA Inspection 1215392 - Novast Laboratories Ltd. - July 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/novast-laboratories-ltd/5337cb22-16e5-4822-a935-ae4d1cb2c461
Source feed: FDA_Inspections

> FDA inspection 1215392 of Novast Laboratories Ltd., July 14, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215392
- Company Name: Novast Laboratories Ltd.
- Inspection Date: 2023-07-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1063128 - 2018-07-13
- FDA Inspection 971042 - 2016-04-15
- FDA Inspection 932973 - 2015-06-05
- FDA Inspection 828491 - 2013-03-29

## Related Officers

- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)

Company: https://www.keypedia.com/companies/novast-laboratories-ltd/09af3717-83af-4da5-a825-e8a0c061d42b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c